Literature DB >> 8132734

Peripheral blood neutrophil production of interleukin-1 receptor antagonist and interleukin-1 beta.

M Malyak1, M F Smith, A A Abel, W P Arend.   

Abstract

The objective of this study was to characterize interleukin-1 receptor antagonist (IL-1ra) and interleukin-1 beta (IL-1 beta) production by human peripheral blood neutrophils (polymorphonuclear leukocytes; PMN). Unstimulated PMN contained IL-1ra protein in the absence of IL-1ra mRNA; IL-1 beta mRNA and protein were undetectable. Lipopolysaccharide (LPS), granulocyte/macrophage colony-stimulating factor (GM-CSF), and tumor necrosis factor-alpha (TNF-alpha), individually, transiently increased IL-1ra steady-state mRNA levels in PMN, with associated increases in IL-1ra protein synthesis. LPS, GM-CSF, and TNF-alpha generated similar increases in IL-1 beta mRNA, yet only LPS resulted in detectable synthesis of IL-1 beta protein. IL-4 enhanced LPS-induced IL-1ra production by PMN and inhibited LPS-induced IL-1 beta production. by PMN and inhibited LPS-induced IL-1 beta production. IL-1ra protein present within stimulated PMN supernatants existed in the 22- to 25-kD glycosylated form. Polymerase chain reaction amplification determined that only sIL-1ra mRNA was present within stimulated PMN; icIL-1ra mRNA was undetectable. These results indicate that freshly isolated PMN possess a small amount of IL-1ra protein and that these cells can respond to stimuli with a low level of sIL-1ra transcription and translation. PMN may be a major source of IL-1ra in inflammatory exudates where these cells predominate.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8132734     DOI: 10.1007/bf01541172

Source DB:  PubMed          Journal:  J Clin Immunol        ISSN: 0271-9142            Impact factor:   8.317


  30 in total

1.  cDNA cloning of an intracellular form of the human interleukin 1 receptor antagonist associated with epithelium.

Authors:  S Haskill; G Martin; L Van Le; J Morris; A Peace; C F Bigler; G J Jaffe; C Hammerberg; S A Sporn; S Fong
Journal:  Proc Natl Acad Sci U S A       Date:  1991-05-01       Impact factor: 11.205

2.  Interleukin-1 receptor antagonist activity of a human interleukin-1 inhibitor.

Authors:  C H Hannum; C J Wilcox; W P Arend; F G Joslin; D J Dripps; P L Heimdal; L G Armes; A Sommer; S P Eisenberg; R C Thompson
Journal:  Nature       Date:  1990-01-25       Impact factor: 49.962

3.  Expression of interleukin-1 alpha and beta genes by human blood polymorphonuclear leukocytes.

Authors:  P C Lord; L M Wilmoth; S B Mizel; C E McCall
Journal:  J Clin Invest       Date:  1991-04       Impact factor: 14.808

4.  Modulation of multiple neutrophil functions by preparative methods or trace concentrations of bacterial lipopolysaccharide.

Authors:  C Haslett; L A Guthrie; M M Kopaniak; R B Johnston; P M Henson
Journal:  Am J Pathol       Date:  1985-04       Impact factor: 4.307

5.  Interleukin 1 (IL-1) gene expression, synthesis, and effect of specific IL-1 receptor blockade in rabbit immune complex colitis.

Authors:  F Cominelli; C C Nast; B D Clark; R Schindler; R Lierena; V E Eysselein; R C Thompson; C A Dinarello
Journal:  J Clin Invest       Date:  1990-09       Impact factor: 14.808

Review 6.  Cytokines and cytokine inhibitors or antagonists in rheumatoid arthritis.

Authors:  W P Arend; J M Dayer
Journal:  Arthritis Rheum       Date:  1990-03

7.  IL-4 up-regulates IL-1 receptor antagonist gene expression and its production in human blood monocytes.

Authors:  E Orino; S Sone; A Nii; T Ogura
Journal:  J Immunol       Date:  1992-08-01       Impact factor: 5.422

8.  Interleukin-1 (IL-1) receptor blockade reduces endotoxin and Borrelia burgdorferi-stimulated IL-8 synthesis in human mononuclear cells.

Authors:  R Porat; D D Poutsiaka; L C Miller; E V Granowitz; C A Dinarello
Journal:  FASEB J       Date:  1992-04       Impact factor: 5.191

9.  Coordinated antiinflammatory effects of interleukin 4: interleukin 4 suppresses interleukin 1 production but up-regulates gene expression and synthesis of interleukin 1 receptor antagonist.

Authors:  E Vannier; L C Miller; C A Dinarello
Journal:  Proc Natl Acad Sci U S A       Date:  1992-05-01       Impact factor: 11.205

10.  Production of IL-1 receptor antagonist by human in vitro-derived macrophages. Effects of lipopolysaccharide and granulocyte-macrophage colony-stimulating factor.

Authors:  R W Janson; K R Hance; W P Arend
Journal:  J Immunol       Date:  1991-12-15       Impact factor: 5.422

View more
  18 in total

1.  [Intra-articular therapy with autologous interleukin-1 receptor antagonist in osteoarthritis. Innovation or quackery?].

Authors:  D Stengel; A Ekkernkamp; M Wich
Journal:  Unfallchirurg       Date:  2004-11       Impact factor: 1.000

2.  Systemic inflammation in COPD visualised by gene profiling in peripheral blood neutrophils.

Authors:  E-J D Oudijk; E H J Nijhuis; M D Zwank; E A van de Graaf; H J Mager; P J Coffer; J-W J Lammers; L Koenderman
Journal:  Thorax       Date:  2005-07       Impact factor: 9.139

3.  Interleukin 1 receptor antagonist (IL-1Ra) is an acute-phase protein.

Authors:  C Gabay; M F Smith; D Eidlen; W P Arend
Journal:  J Clin Invest       Date:  1997-06-15       Impact factor: 14.808

4.  Leucocyte response and anti-inflammatory cytokines in community acquired pneumonia.

Authors:  U K Kolling; F Hansen; J Braun; L Rink; H A Katus; K Dalhoff
Journal:  Thorax       Date:  2001-02       Impact factor: 9.139

5.  Mechanisms of endotoxin tolerance in patients with alcoholic liver cirrhosis: role of interleukin 10, interleukin 1 receptor antagonist, and soluble tumour necrosis factor receptors as well as effector cell desensitisation.

Authors:  V von Baehr; W D Döcke; M Plauth; C Liebenthal; S Küpferling; H Lochs; R Baumgarten; H D Volk
Journal:  Gut       Date:  2000-08       Impact factor: 23.059

6.  The role of interleukin-1beta in direct and toll-like receptor 4-mediated neutrophil activation and survival.

Authors:  Lynne R Prince; Lucy Allen; Elizabeth C Jones; Paul G Hellewell; Steven K Dower; Moira K B Whyte; Ian Sabroe
Journal:  Am J Pathol       Date:  2004-11       Impact factor: 4.307

7.  Clinical response is associated with elevated plasma interleukin-1 receptor antagonist during selective granulocyte and monocyte apheresis in patients with ulcerative colitis.

Authors:  Kyoya Sakimura; Toshihide Omori; Etsuro Iwashita; Takeshi Yoshida; Yoshikazu Tsuzuki; Kenji Fujimori; Fumio Konishi; Yukio Yoshida; Hiroo Anzai; Hiromichi Suzuki; Souichi Sugawara; Yuji Takeda; Katsuya Hiraishi; Abbi R Saniabadi; Tatsuo Ide; Soichiro Miura; Shinichi Ota
Journal:  Dig Dis Sci       Date:  2006-08-12       Impact factor: 3.199

8.  Polymorphisms of the IL1-receptor antagonist gene (IL1RN) are associated with multiple markers of systemic inflammation.

Authors:  Alexander P Reiner; Mark M Wurfel; Leslie A Lange; Christopher S Carlson; Alex S Nord; Cara L Carty; Mark J Rieder; Cindy Desmarais; Nancy S Jenny; Carlos Iribarren; Jeremy D Walston; O Dale Williams; Deborah A Nickerson; Gail P Jarvik
Journal:  Arterioscler Thromb Vasc Biol       Date:  2008-05-01       Impact factor: 8.311

Review 9.  Treatment of rheumatoid arthritis with IL-1 inhibitors.

Authors:  C Gabay; W P Arend
Journal:  Springer Semin Immunopathol       Date:  1998

10.  Regulatory effects of endogenous interleukin-1 receptor antagonist protein in immunoglobulin G immune complex-induced lung injury.

Authors:  T P Shanley; J L Peters; M L Jones; S W Chensue; S L Kunkel; P A Ward
Journal:  J Clin Invest       Date:  1996-02-15       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.